Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Zelluna ASA
Entity

Zelluna ASA

Tracked across 2 events · 13 articles · First seen Jun 17, 2026 · Last active Aug 10, 2026

Sentiment
15
Attention
3
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
3 20
Business
Zelluna ASA Private Placement Completed
Impact: Zelluna ASA completed a private placement of new shares, increasing its capital and share count. This event impacts its ownership structure and potentially its stock valuation.
Jun 17, 2026 · 6 articles
1 10
Business
Zelluna issues shares to Inven2
Zelluna ASA, a biotech company developing TCR-NK cell therapies for solid cancers, issued 446,752 new shares to Inven2 AS at a subscription price of NOK 19.7752 per share, increasing its share capital from NOK 29,413,759…
Impact: Zelluna issued new shares to settle a debt, increasing its share capital. This reflects progress in its clinical program and maintains its relationship with Inven2.
Aug 04, 2026 · 7 articles
Key Actions (2)
80 Zelluna ASA issued shares Inven2 ASZelluna issues shares to Inven2
70 Zelluna ASA completed private placementZelluna issues shares to Inven2
ERGEN INTELLIGENCE
Track Zelluna ASA live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.